• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丝裂原活化蛋白激酶(MAPK)信号通路的磷酸化蛋白质组分析揭示了以前未被发现的反馈机制。

Phosphoproteome analysis of the MAPK pathway reveals previously undetected feedback mechanisms.

作者信息

Gnad Florian, Doll Sophia, Song Kyung, Stokes Matthew P, Moffat John, Liu Bonnie, Arnott David, Wallin Jeffrey, Friedman Lori S, Hatzivassiliou Georgia, Belvin Marcia

机构信息

Department of Bioinformatics and Computational Biology, Genentech Inc, South San Francisco, CA, USA.

Department of Protein Chemistry, Genentech Inc, South San Francisco, CA, USA.

出版信息

Proteomics. 2016 Jul;16(14):1998-2004. doi: 10.1002/pmic.201600119.

DOI:10.1002/pmic.201600119
PMID:27273156
Abstract

The RAS-RAF-MEK-ERK (MAPK) pathway is prevalently perturbed in cancer. Recent large-scale sequencing initiatives profiled thousands of tumors providing insight into alterations at the DNA and RNA levels. These efforts confirmed that key nodes of the MAPK pathway, in particular KRAS and BRAF, are among the most frequently altered proteins in cancer. The establishment of targeted therapies, however, has proven difficult. To decipher the underlying challenges, it is essential to decrypt the phosphorylation network spanned by the MAPK core axis. Using mass spectrometry we identified 2241 phosphorylation sites on 1020 proteins, and measured their responses to inhibition of MEK or ERK. Multiple phosphorylation patterns revealed previously undetected feedback, as upstream signaling nodes, including receptor kinases, showed changes at the phosphorylation level. We provide a dataset rich in potential therapeutic targets downstream of the MAPK cascade. By integrating TCGA (The Cancer Genome Atlas) data, we highlight some downstream phosphoproteins that are frequently altered in cancer. All MS data have been deposited in the ProteomeXchange with identifier PXD003908 (http://proteomecentral.proteomexchange.org/dataset/PXD003908).

摘要

RAS-RAF-MEK-ERK(丝裂原活化蛋白激酶)信号通路在癌症中普遍受到干扰。最近的大规模测序计划对数千个肿瘤进行了分析,从而深入了解了DNA和RNA水平的改变。这些研究证实,丝裂原活化蛋白激酶信号通路的关键节点,尤其是KRAS和BRAF,是癌症中最常发生改变的蛋白质之一。然而,靶向治疗的建立已被证明是困难的。为了解释潜在的挑战,解密丝裂原活化蛋白激酶核心轴所跨越的磷酸化网络至关重要。我们使用质谱法鉴定了1020种蛋白质上的2241个磷酸化位点,并测量了它们对MEK或ERK抑制的反应。多种磷酸化模式揭示了以前未检测到的反馈,因为包括受体激酶在内的上游信号节点在磷酸化水平上发生了变化。我们提供了一个富含丝裂原活化蛋白激酶级联下游潜在治疗靶点的数据集。通过整合癌症基因组图谱(TCGA)数据,我们突出了一些在癌症中经常发生改变的下游磷酸化蛋白。所有质谱数据已存入蛋白质组交换库,标识符为PXD003908(http://proteomecentral.proteomexchange.org/dataset/PXD003908)。

相似文献

1
Phosphoproteome analysis of the MAPK pathway reveals previously undetected feedback mechanisms.丝裂原活化蛋白激酶(MAPK)信号通路的磷酸化蛋白质组分析揭示了以前未被发现的反馈机制。
Proteomics. 2016 Jul;16(14):1998-2004. doi: 10.1002/pmic.201600119.
2
Quantitative phosphoproteomic analysis of the PI3K-regulated signaling network.PI3K调节信号网络的定量磷酸化蛋白质组学分析
Proteomics. 2016 Jul;16(14):1992-7. doi: 10.1002/pmic.201600118. Epub 2016 Jul 8.
3
[Focus on targeting the Ras-MAPK pathway: the Mek inhibitors].聚焦于靶向Ras-MAPK通路:丝裂原活化蛋白激酶激酶抑制剂
Bull Cancer. 2012 Sep;99(9):865-74. doi: 10.1684/bdc.2012.1632.
4
Raf-1 kinase activation is uncoupled from downstream MEK/ERK pathway in cells treated with Src tyrosine kinase inhibitor PP2.在使用Src酪氨酸激酶抑制剂PP2处理的细胞中,Raf-1激酶激活与下游MEK/ERK途径解偶联。
Biochem Biophys Res Commun. 2006 Nov 17;350(2):450-6. doi: 10.1016/j.bbrc.2006.09.067. Epub 2006 Sep 22.
5
Time-resolved Phosphoproteome Analysis of Paradoxical RAF Activation Reveals Novel Targets of ERK.反常RAF激活的时间分辨磷酸化蛋白质组分析揭示了ERK的新靶点。
Mol Cell Proteomics. 2017 Apr;16(4):663-679. doi: 10.1074/mcp.M116.065128. Epub 2017 Feb 10.
6
Resistance to MEK inhibitors: should we co-target upstream?对 MEK 抑制剂的耐药性:我们是否应该共同针对上游靶点?
Sci Signal. 2011 Mar 29;4(166):pe16. doi: 10.1126/scisignal.2001948.
7
Radicicol suppresses transformation and restores tropomyosin-2 expression in both ras- and MEK-transformed cells without inhibiting the Raf/MEK/ERK signaling cascade.萝卜硫素可抑制ras和MEK转化细胞的转化并恢复原肌球蛋白-2的表达,且不会抑制Raf/MEK/ERK信号级联反应。
Cell Growth Differ. 2001 Nov;12(11):543-50.
8
FOXD3 is a tumor suppressor of colon cancer by inhibiting EGFR-Ras-Raf-MEK-ERK signal pathway.FOXD3通过抑制EGFR-Ras-Raf-MEK-ERK信号通路,成为结肠癌的一种肿瘤抑制因子。
Oncotarget. 2017 Jan 17;8(3):5048-5056. doi: 10.18632/oncotarget.13790.
9
Effects of MEK inhibitors GSK1120212 and PD0325901 in vivo using 10-plex quantitative proteomics and phosphoproteomics.使用10重定量蛋白质组学和磷酸化蛋白质组学研究MEK抑制剂GSK1120212和PD0325901在体内的作用。
Proteomics. 2015 Jan;15(2-3):462-73. doi: 10.1002/pmic.201400154. Epub 2014 Oct 18.
10
Novel mitogen-activated protein kinase kinase inhibitors.新型丝裂原活化蛋白激酶激酶抑制剂。
Expert Opin Investig Drugs. 2011 Feb;20(2):209-20. doi: 10.1517/13543784.2011.548803.

引用本文的文献

1
Impact of the changes in substrate specificity of herpes simplex virus 1 protein kinase Us3 on viral infection and .单纯疱疹病毒1型蛋白激酶Us3底物特异性变化对病毒感染的影响以及…… (原文结尾不完整)
J Virol. 2025 Jul 22;99(7):e0040025. doi: 10.1128/jvi.00400-25. Epub 2025 Jun 30.
2
ERK1/2: An Integrator of Signals That Alters Cardiac Homeostasis and Growth.细胞外信号调节激酶1/2:改变心脏内环境稳定与生长的信号整合因子
Biology (Basel). 2021 Apr 20;10(4):346. doi: 10.3390/biology10040346.
3
Investigation of GTP-dependent dimerization of G12X K-Ras variants using ultraviolet photodissociation mass spectrometry.
使用紫外光解离质谱法研究G12X K-Ras变体的GTP依赖性二聚化。
Chem Sci. 2019 Jul 15;10(34):8025-8034. doi: 10.1039/c9sc01032g. eCollection 2019 Sep 14.
4
Effects of PHA-665752 and vemurafenib combination treatment on and murine xenograft growth of human colorectal cancer cells with BRAF mutations.PHA-665752与维莫非尼联合治疗对携带BRAF突变的人结肠癌细胞的作用及小鼠异种移植瘤生长的影响
Oncol Lett. 2018 Mar;15(3):3904-3910. doi: 10.3892/ol.2018.7770. Epub 2018 Jan 10.